The PhRMA Foundation has announced grants totaling $1,000,000 as part of its Value Assessment Initiative. The aim of the initiative is to develop transformative, multi-stakeholder-driven solutions that address challenges in assessing the value of medicines and healthcare services and ultimately improve patient outcomes and reduce inefficiency. The $1,000,000 will be distributed to new centers located at Tufts Medical Center and the University of Colorado.
Tufts’ Center for Enhanced Value Assessment (CEVA) will be directed by Peter J. Neumann, ScD. CEVA’s mission will include: exploring development of additional value elements; engaging patients and stakeholders to identify important novel and non-standard elements; and reporting findings back to stakeholders.
The University of Colorado’s Center for Pharmaceutical Value (PValue), under the direction of Jonathan D. Campbell, PhD, will apply and test novel methods to improve the pharmaceutical coverage and reimbursement decision-making process, with the goal of improving transparency, consistency, and personalization of decisions through multi-criteria decision analysis (MCDA).